A study involving School of Medicine researchers supports the idea that some T cells that react to microbes also may react to normal human proteins, causing autoimmune disease. The findings promise to accelerate efforts to improve diagnostic tools and treatments for autoimmune diseases.
Researchers at the School of Medicine have discovered that vaccinating mice against a bacterial toxin produced by E. coli can prevent intestinal damage. The finding suggests new ways to prevent malnutrition and stunting in children.
A nationwide team studied 44,000 smokers at 28 cancer centers, including Siteman Cancer Center, and learned that if they could get such patients into nicotine replacement, counseling or both, they could help nearly one in five quit smoking, while also boosting cancer survival rates.
School of Medicine scientists have shown that the cancer therapy known as CAR-T can be applied to multiple sclerosis (MS), an autoimmune disease of the nervous system. The findings extend the powerful tool of immunotherapy to autoimmune diseases, a class of diseases that are often debilitating and difficult to treat.
A research team that includes School of Medicine and pharmacy scientists has altered the chemical properties of fentanyl. The research holds promise for developing safer opioid drugs that still relieve pain.
Research from Quing Zhu’s lab at the McKelvey School of Engineering yields a novel method to use ultrasound to enhance machine learning’s ability to accurately diagnose — or rule out — ovarian cancer.
A new study by researchers at Washington University School of Medicine found that undergoing more frequent computed tomography (CT) scans was not associated with improved outcomes following lung cancer surgery.
Janet S. Lee, MD, a highly regarded physician-scientist in pulmonary and critical care medicine, has been chosen to lead the Division of Pulmonary & Critical Care Medicine in the Department of Medicine at the School of Medicine. Her appointment is effective Jan. 3.
Researchers at Washington University School of Medicine have discovered a biomarker for a rare, deadly brain disease known as corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD.
A drug compound attacks hard-to-treat prostate cancer on several fronts, according to a School of Medicine study in mice and human cells. It triggers immune cells to attack, helps the immune cells penetrate the tumor and cuts off the tumor’s ability to burn testosterone as fuel.
View More Stories